# A (M)Ulti-center, Prospective, (O)Pen Label, Uncontrolled Feasibility (S)Tudy to Assess the Safety and Effectiveness of an Automatic Low Flow (A)Scites (Alfa) Pump (I)n Patients With (C)Irrhosis and Refractory or Recurrent Ascites

> **NCT02400164** · NA · COMPLETED · sponsor: **Sequana Medical N.V.** · enrollment: 30 (actual)

## Conditions studied

- Cirrhosis
- Ascites

## Interventions

- **DEVICE:** alfapump system

## Key facts

- **NCT ID:** NCT02400164
- **Lead sponsor:** Sequana Medical N.V.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-03
- **Primary completion:** 2018-01-19
- **Final completion:** 2018-03-31
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2018-04-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02400164

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02400164, "A (M)Ulti-center, Prospective, (O)Pen Label, Uncontrolled Feasibility (S)Tudy to Assess the Safety and Effectiveness of an Automatic Low Flow (A)Scites (Alfa) Pump (I)n Patients With (C)Irrhosis and Refractory or Recurrent Ascites". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02400164. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*